NONMEM Users Network Archive

Hosted by Cognigen

PhD student and postdoc positions at the University of Cape Town

From: Paolo Denti <paolo.denti>
Date: Tue, 25 Aug 2020 12:36:51 +0200

Dear all,
Our pharmacometrics group is looking for bright and motivated candidates
to join our modelling team within the Division of Clinical Pharmacology
at the University of Cape Town.

Our group has established PK/PD modelling expertise in the disease areas
of tuberculosis, HIV, and malaria. It is active internationally and
enjoys on-going collaborations and exchange programs with some of the
main pharmacometric research groups worldwide.

Scholarships at both PhD student and postdoc level are available, please
refer to the links below for more details.
PhD student -
Postdoc -

To apply, or for any further information, please contact
of motivation. The application deadline is September 30th 2020. However,
enquiries regarding future positions are welcome.

For more information about our research, you can Google “pharmacome=
Cape Town”.
For any extracurricular reasons to move to the beautiful Mother City of
Africa, you may Google simply “Cape Town” instead, and clic=
k on “Images”.
Bonus perk of the job: you get to save on your flight and accommodation
to attend the World Conference on Pharmacometrics 2022 -


Paolo Denti, PhD
A/Prof of Pharmacometrics
Division of Clinical Pharmacology
Department of Medicine
University of Cape Town

K45 Old Main Building
Groote Schuur Hospital
Observatory, Cape Town
7925 South Africa
phone: +27 21 404 7719
fax: +27 021 650 5410

Disclaimer - University of Cape Town This email is subject to UCT policies =
and email disclaimer published on our website at
email-disclaimer or obtainable from +27 21 650 9111. If this email is not r=
elated to the business of UCT, it is sent by the sender in an individual ca=
pacity. Please report security incidents or abuse via

Received on Tue Aug 25 2020 - 06:36:51 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: